Published in PLoS One on November 25, 2009
Early Versus Delayed Routine HIV Testing in Connecticut Jails (SWAB) | NCT00624247
Public health implications for adequate transitional care for HIV-infected prisoners: five essential components. Clin Infect Dis (2011) 2.12
Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate. JAMA Intern Med (2014) 1.86
Public health and the epidemic of incarceration. Annu Rev Public Health (2012) 1.85
Opportunities to diagnose, treat, and prevent HIV in the criminal justice system. J Acquir Immune Defic Syndr (2010) 1.62
Diversity of release patterns for jail detainees: implications for public health interventions. Am J Public Health (2011) 1.27
HIV-related research in correctional populations: now is the time. Curr HIV/AIDS Rep (2011) 1.25
Optimizing care for HIV-infected people who use drugs: evidence-based approaches to overcoming healthcare disparities. Clin Infect Dis (2013) 1.24
The HIV Care Cascade Before, During, and After Incarceration: A Systematic Review and Data Synthesis. Am J Public Health (2015) 1.11
HIV among persons incarcerated in the USA: a review of evolving concepts in testing, treatment, and linkage to community care. Curr Opin Infect Dis (2013) 1.07
Rapid HIV testing in large urban jails. Am J Public Health (2012) 1.05
A cluster randomized trial of utilizing a local change team approach to improve the delivery of HIV services in correctional settings: study protocol. Health Justice (2013) 0.93
An evaluation of a routine opt-out rapid HIV testing program in a Rhode Island jail. AIDS Educ Prev (2011) 0.88
Evidence-based interventions to enhance assessment, treatment, and adherence in the chronic Hepatitis C care continuum. Int J Drug Policy (2015) 0.88
Correlates of HIV infection and being unaware of HIV status among soon-to-be-released Ukrainian prisoners. J Int AIDS Soc (2014) 0.87
The feasibility of implementing the HIV seek, test, and treat strategy in jails. AIDS Patient Care STDS (2014) 0.85
HIV treatment in US prisons. HIV Ther (2010) 0.85
A stepped wedge cluster randomized control trial of dried blood spot testing to improve the uptake of hepatitis C antibody testing within UK prisons. Eur J Public Health (2014) 0.85
HIV prevention for adults with criminal justice involvement: a systematic review of HIV risk-reduction interventions in incarceration and community settings. Am J Public Health (2014) 0.79
Routine testing for blood-borne viruses in prisons: a systematic review. Eur J Public Health (2015) 0.78
Establishing an HIV Screening Program Led by Staff Nurses in a County Jail. J Public Health Manag Pract (2016) 0.78
Intersecting epidemics of HIV, HCV, and syphilis among soon-to-be released prisoners in Kyrgyzstan: Implications for prevention and treatment. Int J Drug Policy (2016) 0.76
Sexual HIV Risk Among Male Parolees and Their Female Partners: The Relate Project. J Health Dispar Res Pract (2015) 0.75
Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep (2006) 37.28
Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs. Ann Intern Med (2006) 5.53
Voluntary rapid human immunodeficiency virus (HIV) testing in jails. Sex Transm Dis (2009) 3.10
Feasibility and acceptability of rapid HIV testing in jail. AIDS Patient Care STDS (2007) 2.52
Comparison of point-of-care rapid HIV testing in three clinical venues. AIDS (2004) 1.45
Cost-effectiveness of HIV counseling and testing in US prisons. J Urban Health (2001) 1.39
Routine opt-out HIV testing strategies in a female jail setting: a prospective controlled trial. PLoS One (2009) 1.33
Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet (2002) 10.48
Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel. Ann Intern Med (2012) 7.04
Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. JAMA (2010) 6.65
Effectiveness of antiretroviral therapy among HIV-infected prisoners: reincarceration and the lack of sustained benefit after release to the community. Clin Infect Dis (2004) 6.27
Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer. J Clin Oncol (2009) 5.11
Effect of Ebola progression on transmission and control in Liberia. Ann Intern Med (2014) 3.96
Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa. Antiviral Res (2009) 3.39
Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial. Lancet Oncol (2013) 3.11
Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis. Clin Cancer Res (2004) 2.96
Adjuvant radiation therapy is associated with improved survival in Merkel cell carcinoma of the skin. J Clin Oncol (2007) 2.93
A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization. Drug Alcohol Depend (2010) 2.38
Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial. Clin Infect Dis (2007) 2.37
Platelet calmodulin levels in adolescent idiopathic scoliosis: do the levels correlate with curve progression and severity? Spine (Phila Pa 1976) (2002) 2.24
Potential medication dosing errors in outpatient pediatrics. J Pediatr (2005) 2.19
The misdiagnosis of epilepsy. BMJ (2002) 2.16
Public health implications for adequate transitional care for HIV-infected prisoners: five essential components. Clin Infect Dis (2011) 2.12
Rates of concussion are lower in National Football League games played at higher altitudes. J Orthop Sports Phys Ther (2014) 2.11
Substance abuse, violence, and HIV in women: a literature review of the syndemic. J Womens Health (Larchmt) (2011) 2.10
Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy. Pharmacoepidemiol Drug Saf (2007) 2.09
Effect of Iyengar yoga therapy for chronic low back pain. Pain (2005) 2.04
Global distribution of novel rhinovirus genotype. Emerg Infect Dis (2008) 2.03
Adherence and persistence among chronic myeloid leukemia patients during second-line tyrosine kinase inhibitor treatment. J Manag Care Spec Pharm (2014) 2.03
Symmetric atlasing and model based segmentation: an application to the hippocampus in older adults. Med Image Comput Comput Assist Interv (2006) 2.00
Genome-wide association mapping to candidate polymorphism resolution in the unsequenced barley genome. Proc Natl Acad Sci U S A (2010) 1.96
Glycan microarray analysis of Candida glabrata adhesin ligand specificity. Mol Microbiol (2008) 1.96
Molecular and pathologic insights from latent HIV-1 infection in the human brain. Neurology (2013) 1.88
Increased mortality and morbidity in mild primary hyperparathyroid patients. The Parathyroid Epidemiology and Audit Research Study (PEARS). Clin Endocrinol (Oxf) (2009) 1.87
In Vivo 3D Digital Atlas Database of the Adult C57BL/6J Mouse Brain by Magnetic Resonance Microscopy. Front Neuroanat (2008) 1.85
Epidemiological characteristics of pandemic influenza H1N1 2009 and seasonal influenza infection. Med J Aust (2009) 1.81
Working towards a simple case definition for influenza surveillance. J Clin Virol (2003) 1.81
Obstructive sleep apnea and dyslipidemia: evidence and underlying mechanism. Sleep Breath (2012) 1.76
Managing HIV/AIDS in correctional settings. Curr HIV/AIDS Rep (2005) 1.76
Enhanced antilymphoma efficacy of CD19-redirected influenza MP1-specific CTLs by cotransfer of T cells modified to present influenza MP1. Blood (2004) 1.75
Prognostic factors in the surgical management of pericardial effusion in the patient with concurrent malignancy. Chest (2004) 1.74
Pharmacokinetic drug interactions between opioid agonist therapy and antiretroviral medications: implications and management for clinical practice. J Acquir Immune Defic Syndr (2006) 1.73
Reduction in antibiotic use among US children, 1996-2000. Pediatrics (2003) 1.71
Evaluation of the effectiveness and efficacy of Iyengar yoga therapy on chronic low back pain. Spine (Phila Pa 1976) (2009) 1.70
Prognostic factors for time to treatment failure and time to 12 months of remission for patients with focal epilepsy: post-hoc, subgroup analyses of data from the SANAD trial. Lancet Neurol (2012) 1.68
The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer. Am Surg (2005) 1.67
Molecular epidemiology of O139 Vibrio cholerae: mutation, lateral gene transfer, and founder flush. Emerg Infect Dis (2003) 1.67
Improved HIV and substance abuse treatment outcomes for released HIV-infected prisoners: the impact of buprenorphine treatment. J Urban Health (2010) 1.66
Increasing drug users' adherence to HIV treatment: results of a peer-driven intervention feasibility study. Soc Sci Med (2002) 1.66
Integration and co-location of HIV/AIDS, tuberculosis and drug treatment services. Int J Drug Policy (2007) 1.65
A risk variant in an miR-125b binding site in BMPR1B is associated with breast cancer pathogenesis. Cancer Res (2009) 1.64
Breath analysis: the approach towards clinical applications. Mini Rev Med Chem (2007) 1.63
Differentiation of naive cord-blood T cells into CD19-specific cytolytic effectors for posttransplantation adoptive immunotherapy. Blood (2005) 1.57
Models for integrating buprenorphine therapy into the primary HIV care setting. Clin Infect Dis (2006) 1.55
Letrozole-, anastrozole-, and tamoxifen-responsive genes in MCF-7aro cells: a microarray approach. Mol Cancer Res (2005) 1.55
A blueprint for telerehabilitation guidelines--October 2010. Telemed J E Health (2011) 1.54
Medication persistence in the treatment of HIV infection: a review of the literature and implications for future clinical care and research. AIDS (2011) 1.52
Efficacy and safety of tiotropium Respimat SMI in COPD in two 1-year randomized studies. Int J Chron Obstruct Pulmon Dis (2010) 1.51
Computer-based intervention in HIV clinical care setting improves antiretroviral adherence: the LifeWindows Project. AIDS Behav (2011) 1.49
HIV, alcohol dependence, and the criminal justice system: a review and call for evidence-based treatment for released prisoners. Am J Drug Alcohol Abuse (2010) 1.48
Testing for HIV, sexually transmitted infections, and viral hepatitis in jails: still a missed opportunity for public health and HIV prevention. J Acquir Immune Defic Syndr (2010) 1.47
Early detection of ovarian cancer: promise and reality. Cancer Treat Res (2002) 1.45
Dasatinib (BMS-354825) inhibits Stat5 signaling associated with apoptosis in chronic myelogenous leukemia cells. Mol Cancer Ther (2007) 1.45
Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas. Blood (2004) 1.44
Extubation versus tracheostomy in withdrawal of treatment-ethical, clinical, and legal perspectives. J Crit Care (2009) 1.44
Comparison of pandemic (H1N1) 2009 and seasonal influenza, Western Australia, 2009. Emerg Infect Dis (2010) 1.43
HIV treatment access and scale-up for delivery of opiate substitution therapy with buprenorphine for IDUs in Ukraine--programme description and policy implications. Int J Drug Policy (2007) 1.40
Code of Conduct on Biosecurity for Biological Resource Centres: procedural implementation. Int J Syst Evol Microbiol (2013) 1.40
Antiretroviral treatment regimen outcomes among HIV-infected prisoners. HIV Clin Trials (2007) 1.39
Correlates of retention in HIV care after release from jail: results from a multi-site study. AIDS Behav (2013) 1.39
Outcomes following PCI in patients with previous CABG: a multi centre experience. Catheter Cardiovasc Interv (2011) 1.37
A systematic review of antiretroviral adherence interventions for HIV-infected people who use drugs. Curr HIV/AIDS Rep (2012) 1.37
Couples' experiences with prostate cancer: focus group research. Oncol Nurs Forum (2002) 1.37
Retention on buprenorphine is associated with high levels of maximal viral suppression among HIV-infected opioid dependent released prisoners. PLoS One (2012) 1.37
Understanding the revolving door: individual and structural-level predictors of recidivism among individuals with HIV leaving jail. AIDS Behav (2013) 1.35
Early detection of adverse drug events within population-based health networks: application of sequential testing methods. Pharmacoepidemiol Drug Saf (2007) 1.35
Use of stabilized inverse propensity scores as weights to directly estimate relative risk and its confidence intervals. Value Health (2009) 1.34
Impact of enhanced services on virologic outcomes in a directly administered antiretroviral therapy trial for HIV-infected drug users. J Acquir Immune Defic Syndr (2006) 1.33
Routine opt-out HIV testing strategies in a female jail setting: a prospective controlled trial. PLoS One (2009) 1.33
Adherence to HIV treatment and care among previously homeless jail detainees. AIDS Behav (2013) 1.33
Implementing methadone maintenance treatment in prisons in Malaysia. Bull World Health Organ (2013) 1.33
Electronic gaming machines: are they the 'crack-cocaine' of gambling? Addiction (2005) 1.33
A cross-regional assessment of the factors affecting ecoliteracy: implications for policy and practice. Ecol Appl (2007) 1.32
HIV control efforts should directly address incarceration. Lancet Infect Dis (2007) 1.31
Strategies for primary HIV prevention that target behavioral change. Clin Infect Dis (2007) 1.31
Strategies to enhance linkages between care for HIV/AIDS in jail and community settings. AIDS Care (2011) 1.31
Clinical care of the HIV-infected drug user. Infect Dis Clin North Am (2007) 1.30
Neurocognitive impairment and HIV risk factors: a reciprocal relationship. AIDS Behav (2010) 1.29
Persistence of virological benefits following directly administered antiretroviral therapy among drug users: results from a randomized controlled trial. J Acquir Immune Defic Syndr (2009) 1.29
Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients. Clin Infect Dis (2001) 1.28
Safety and pharmacokinetic evaluation of intravenous vaccinia immune globulin in healthy volunteers. Clin Infect Dis (2004) 1.27
Mechanically assisted 3D ultrasound guided prostate biopsy system. Med Phys (2008) 1.27
Clinical outcomes of hepatitis C treatment in a prison setting: feasibility and effectiveness for challenging treatment populations. Clin Infect Dis (2008) 1.26
HIV-related research in correctional populations: now is the time. Curr HIV/AIDS Rep (2011) 1.25
Optimizing care for HIV-infected people who use drugs: evidence-based approaches to overcoming healthcare disparities. Clin Infect Dis (2013) 1.24
SKI-606 (bosutinib), a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells. Mol Cancer Ther (2008) 1.23
The impact of needle exchange-based health services on emergency department use. J Gen Intern Med (2002) 1.22
Adaptation of an evidence-based intervention targeting HIV-infected prisoners transitioning to the community: the process and outcome of formative research for the Positive Living Using Safety (PLUS) intervention. AIDS Patient Care STDS (2009) 1.22
Affinity of galectin-8 and its carbohydrate recognition domains for ligands in solution and at the cell surface. Glycobiology (2007) 1.21
Mortality in sickle cell patients on hydroxyurea therapy. Blood (2004) 1.19
Analysis of breath, exhaled via the mouth and nose, and the air in the oral cavity. J Breath Res (2008) 1.18